PGY2 Oncology Residency Graduates
Rachel Gilmore, PharmD (2022-2023)
Pharmacy School: University of North Carolina Eshelman School of Pharmacy
PGY1 Program: Vanderbilt University Medical Center
Research Project: Efficacy and Safety of a Novel Non-Myeloablative Conditioning Regimen for Hematopoietic Cell Transplantation in Adults with Severe Aplastic Anemia
First Position Following Graduation: Outpatient Pediatric Hematology/Oncology Clinical Pharmacy Specialist, Cleveland Clinic in Cleveland,OH
Karin Aberbathy, PharmD (2021-2022)
Pharmacy School: University of North Carolina Eshelman School of Pharmacy
PGY1 Program: Vanderbilt University Medical Center
Research Project: Evaluation of the Safety of Concurrent Tyrosine Kinase Inhibitor Use and Radiation in Non-Small Cell Lung Cancer Patients
First Position Following Graduation: Stem Cell Transplant & Cellular Therapy Clinical Pharmacy Specialist, TriStar Centennial Hospital in Nashville, TN
Lindsay Orton, PharmD (2020-2021)
Pharmacy School: West Virginia School of Pharmacy
PGY1 Program: Vanderbilt University Medical Center
Research Project: Evaluating the Clinical Benefit of Post-Transplant DNA Methyltransferase Inhibitor Maintenance Therapy in Myelodysplastic Syndrome and Acute Myeloid Leukemia
First Position Following Graduation: Stem Cell Transplant & Cellular Therapy Clinical Pharmacy Specialist, Vanderbilt University Medical Center in Nashville, TN
Brendan Mangan, PharmD (2019-2020)
Pharmacy School: Temple University School of Pharmacy
PGY1 Program: Vanderbilt University Medical Center in Nashville, TN
Research Project: Implications of Myelosuppression with Venetoclax in Combination with Hypomethylating Agents or Cytarabine in Acute Myeloid Leukemia
First Position Following Graduation: Oncology Clinical Pharmacy Specialist, Hospital of The University of Pennsylvania
Shelby Merchant, PharmD (2018-2019)
Pharmacy School: University of South Carolina
PGY1 Program: Carolina’s Medical Center in Charlotte, NC
Research Project: Efficacy Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Transplant Recipients
First Position Following Graduation: Oncology Clinical Pharmacy Specialist, Memorial Sloan Kettering Cancer Center
Jordan Baskett, PharmD (2017-2018)
Pharmacy School: University of North Carolina Eshelman School of Pharmacy
PGY1 Program: Vidant Medical Center
Research Project: Risk factors for viral infections following haploidentical hematopoietic stem cell transplant with post-transplant cyclophosphamide in patients with various hematologic disorders: a single center experience
First Position Following Graduation: Inpatient Oncology Clinical Pharmacist, Duke Cancer Institute
Renee McAlister, PharmD, BCOP (2016-2017)
Pharmacy School: University of Illinois at Chicago
PGY1 Program: VA Puget Sound Health Care
Research Project: Effect of concomitant pH-elevating medications with pazopanib on overall survival and progression-free survival in patients with metastatic renal cell carcinoma
First Position Following Graduation: Oncology Clinical Pharmacist, Renal Cell Carcinoma/Melanoma Clinic, Vanderbilt University Medical Center
Bridgette Kanz Schroader, PharmD, BCOP (2015-2016)
Pharmacy School: University of Kentucky College of Pharmacy
PGY1 Program: Vanderbilt University Medical Center
PGY2 Research Project: Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
First Position Following Graduation: Hematology/Oncology Clinical Pharmacist in the Multi-Disciplinary Oncology Clinic- University of Kentucky Markey Cancer Center; Assistant Director, Oncology Medical Communications, Xcenda
Andrew Bodiford, PharmD, BCOP (2014-2015)
Pharmacy School: Medical University of South Carolina College of Pharmacy
PGY1 Program: Vanderbilt University Medical Center
PGY2 Research Project: Impact of PREDICT pharmacogenomics on efficacy and safety of tacrolimus dosing in allogeneic stem cell transplant patients
First Position Following Graduation: Malignant Hematology Clinical Pharmacy Specialist- Medical University of South Carolina
Megan Bodge, PharmD, BCOP (2013-2014)
Pharmacy School: West Virginia University School of Pharmacy
PGY1 Program: West Virginia University Medicine, J.W. Ruby Memorial Hospital
PGY2 Research Project: Review of allogeneic hematopoietic stem cell transplantation outcomes in the setting of pre-transplant kidney or liver impairment
First Position Following Graduation: Clinical Pharmacy Specialist, Bone Marrow Transplant - West Virginia University Medicine, J.W. Ruby Memorial Hospital
Megan Pollack, PharmD, BCOP (2012-2013)
Pharmacy School: University of Florida College of Pharmacy
PGY1 Program: Vanderbilt University Medical Center
PGY2 Research Project: Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer
First Position Following Graduation: Assistant Director, Oncology Medical Communications, Xcenda
Mona Benrashid, PharmD, BCOP (2011-2012)
Pharmacy School: Campbell University College of Pharmacy and Health Sciences
PGY1 Program: CaroMont Regional Medical Center
PGY2 Research Project: Prevalence of vitamin D deficiency after allogeneic stem cell transplantation and its relation to graft versus‐host‐disease
First Position Following Graduation: Oncology Clinical Pharmacist, Breast Clinic, Vanderbilt University Medical Center